Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC

被引：0
|
作者：
Wilhelm Graf
Peter H. Cashin
Lana Ghanipour
Malin Enblad
Johan Botling
Alexei Terman
Helgi Birgisson
机构：
[1] Uppsala University,Department of Surgical Sciences, Akademiska sjukhuset
[2] Uppsala University,Department of Immunology, Genetics and Pathology, Clinical and Experimental Pathology, Akademiska sjukhuset
来源：
Annals of Surgical Oncology | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：293 / 300
页数：7
相关论文
共 50 条
  • [31] ASO Visual Abstract: In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is Not a Prognostic Marker for Survival
    Ibrahim Said
    Inge Ubink
    Roos S. G. Ewalds
    Johanna G. T. Arkesteijn
    Henk M. W. Verheul
    Johannes H. W. de Wilt
    Helena M. Dekker
    Andreas J. A. Bremers
    Philip R. de Reuver
    Annals of Surgical Oncology, 2022, 29 : 5263 - 5264
  • [32] Prognostic impact of KRAS and BRAF mutations in patients who underwent simultaneous resection for initially resectable colorectal liver metastases
    Lin, Qi
    Jian, Mi
    Niu, Zheng-Chuan
    Xu, Ping-Ping
    Zheng, Peng
    Xu, Jian-Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (12): : 5981 - 5991
  • [33] ASO Visual Abstract: In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is Not a Prognostic Marker for Survival
    Said, Ibrahim
    Ubink, Inge
    Ewalds, Roos S. G.
    Arkesteijn, Johanna G. T.
    Verheul, Henk M. W.
    de Wilt, Johannes H. W.
    Dekker, Helena M.
    Bremers, Andreas J. A.
    de Reuver, Philip R.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (8) : 5263 - 5264
  • [34] Mutation profile of KRAS and BRAF genes in patients with colorectal cancer: association with morphological and prognostic criteria
    Samara, M.
    Kapatou, K.
    Ioannou, M.
    Kostopoulou, E.
    Papamichali, R.
    Papandreou, C.
    Athanasiadis, A.
    Koukoulis, G.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 16793 - 16802
  • [35] Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies
    Harper, Megan M.
    Kim, Joseph
    Pandalai, Prakash K.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [36] Novel Prognostic Scoring System for Prediction of Survival Outcomes in Patients undergoing CRS-HIPEC for Colorectal Peritoneal Metastasis
    Chin, K.
    Tan, G.
    Chia, C.
    Ong, J. C.
    Teo, M.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S114 - S115
  • [37] Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients
    Rako, I.
    Jakic-Razumovic, J.
    Katalinic, D.
    Sertic, J.
    Plestina, S.
    NEOPLASMA, 2012, 59 (04) : 376 - 383
  • [38] Hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases: lessons learned from PRODIGE 7
    Cashin, Peter
    Sugarbaker, Paul H.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 : S120 - S128
  • [39] Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Sammartino P.
    Biacchi D.
    Cornali T.
    Cardi M.
    Accarpio F.
    Impagnatiello A.
    Sollazzo B.M.
    Di Giorgio A.
    Indian Journal of Surgical Oncology, 2016, 7 (2) : 215 - 224
  • [40] Can Elderly Patients with Peritoneal Metastasis Induced by Appendiceal or Colorectal Tumours Benefit from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
    Zhou, Sicheng
    Feng, Qiang
    Zhang, Jing
    Zhou, Haitao
    Jiang, Zheng
    Liang, Jianwei
    Pei, Wei
    Liu, Qian
    Zhou, Zhixiang
    Wang, Xishan
    CLINICAL INTERVENTIONS IN AGING, 2021, 16 : 559 - 568
12345